Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Lion Biotechnologies
Work at Lion Biotechnologies?
Add yourself to this profile
3326
Lion Biotechnologies
We are a publicly traded #biotech company focused on the development of novel #cancer #immunotherapy products for #melanoma and other solid tumors.
Edit Profile
lbio.com
Health Care
>
Medical
Health Care
Technology
>
Biotechnology
B2c
Founded in
2013
Inactive
Raised
$100M
More info
Elsewhere
Companies in the same industry
Congenica
Pfizer Inc.
Ritter Pharmaceuticals, Inc.
Prospective Research
Immortagen
Esperion Therapeutics
Creative Bioarray
Genomind
Bedi OralCare
Fibrocell Science
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
Post-IPO equity
$100,000,000
Frazier Healthcare Partners
,
OrbiMed Advisors
,
Broadfin Capital
, +1
Employees
Unknown size
Locations
HQ
United States
Headquarters
The Motley Fool
Why Lion Biotechnologies Inc. Stock Is Roaring Higher Today
$100,000,000
Post-IPO equity
PE Hub
Lion Biotechnologies racks up $100 mln, also hires new president/CEO
Congenica
Pfizer Inc.
Ritter Pharmaceuticals, Inc.
Prospective Research
Immortagen
Creative Bioarray
Genomind
Bedi OralCare